Transaction in Own Shares

Summary by AI BETAClose X

QinetiQ Group plc has purchased a total of 363,900 ordinary shares for cancellation between August 17 and August 21, 2026, as part of its ongoing share buyback program. The weighted average purchase price across all transactions was approximately 547.6 pence per share, with individual trades ranging from 536.00 pence to 561.00 pence. Following these purchases, the company's total number of ordinary shares in issue is now 515,319,569.

Disclaimer*

QinetiQ Group plc
25 August 2026
 

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that during the period 17 August 2026 to 21 August 2026 it purchased in aggregate 363,900 ordinary shares of 1 pence each (Shares) for cancellation through Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis), in accordance with the authority granted by shareholders at the Annual General Meeting of the Company held on 16 July 2026 and pursuant to the latest tranche of its existing share buyback programme announced on 25 March 2026. Full details are set out below:

 

Date

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share

(GBp)

Highest price paid per share

(GBp)

17 August

2026

London Stock Exchange

557.5969

41,500

554.00

561.00

Chi-X

(CXE)

557.6311

15,000

554.50

559.50

BATS

(BXE)

557.5806

15,000

554.50

560.00

18 August

2026

London Stock Exchange

551.8602

40,000

549.50

555.00

Chi-X

(CXE)

551.4541

16,000

549.50

554.00

BATS

(BXE)

551.4633

16,000

549.00

554.00

19 August

2026

London Stock Exchange

546.2302

40,000

541.50

549.50

Chi-X

(CXE)

545.4966

16,500

541.00

548.00

BATS

(BXE)

545.4957

16,500

541.00

548.00

20 August

2026

London Stock Exchange

542.4165

40,000

538.00

546.50

Chi-X

(CXE)

542.8418

16,500

539.00

546.50

BATS

(BXE)

542.8569

17,000

539.00

546.50

21 August

2026

London Stock Exchange

540.3065

40,000

536.00

542.50

Chi-X

(CXE)

540.9918

16,900

538.50

543.00

BATS

(BXE)

540.9995

17,000

538.50

543.00

 

All shares purchased by the Company will be cancelled. 

Following settlement of the above transactions, the Company's total number of ordinary shares in issue, and its total voting rights, will be 515,319,569 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any ordinary shares in treasury.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended, a full breakdown of the individual trades made by Deutsche Numis on behalf of the Company is available via the link below.


http://www.rns-pdf.londonstockexchange.com/rns/9370R_1-2026-8-24.pdf

This announcement will also be available on QinetiQ Group plc's website at: https://www.qinetiq.com/en/investors.

Enquiries to:


Andrew Carter, Group Director Investor Relations:

+44 (0) 7392 289116

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings